Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Heat shock protein family E member 1 pseudogene 13 (HSPE1P13) is a human pseudogene related to the heat shock protein family E (HSP10) genes.** Unlike its parent gene HSPE1, which encodes a mitochondrial chaperonin involved in proper protein folding during cellular stress, HSPE1P13 does not encode a functional protein and is cataloged as a non-functional pseudogene in sources such as BioGPS, GeneCards, and Thermo Fisher[1][4][5]. There is no evidence from authoritative genomic or biomedical databases that HSPE1P13 is itself a therapeutic target, nor does it produce a receptor, enzyme, transporter, or other canonical drug target protein[1][4][5]. Pseudogenes can sometimes play *regulatory roles*, such as acting as decoys for microRNAs or affecting parental gene expression, but there is no experimental evidence in the literature specifically attributing such regulatory or disease-associated roles to HSPE1P13 (as opposed to some other, better-characterized pseudogenes)[2]. No alternative names or commonly used aliases are reported for HSPE1P13 beyond the systematic nomenclature[1][5]. There are no known drugs, mechanisms of action, established biomarker roles, or safety concerns specific to this locus[4][5]. **Summary judgment:** - **HSPE1P13 is not a canonical drug target or functional protein.** - The name is valid (not misspelled), but its nature as a pseudogene renders it non-applicable for most drug discovery/targeting queries (i.e., "is_incorrect" is true in this context). - No structured data for druggability, biomarker status, or therapeutic relevance is applicable. References supporting these statements: [1][4][5] General context on pseudogene potential functions but not specific to HSPE1P13: [2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family E member 1 pseudogene 13 (HSPE1P13).